Assetmark Inc. Sells 98,706 Shares of Lam Research Corporation $LRCX

Assetmark Inc. reduced its stake in Lam Research Corporation (NASDAQ:LRCX) by 26.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 269,937 shares of the semiconductor company’s stock after selling 98,706 shares during the period. Assetmark Inc.’s holdings in Lam Research were worth $26,276,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. grew its position in Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after acquiring an additional 8,364,375 shares during the period. Invesco Ltd. boosted its stake in shares of Lam Research by 2.8% in the 1st quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company’s stock valued at $1,259,947,000 after purchasing an additional 472,636 shares in the last quarter. Nordea Investment Management AB boosted its stake in shares of Lam Research by 34.1% in the 2nd quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock valued at $1,029,210,000 after purchasing an additional 2,692,189 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Lam Research by 25.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 9,536,708 shares of the semiconductor company’s stock worth $693,319,000 after purchasing an additional 1,953,221 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Lam Research by 4.9% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 8,900,506 shares of the semiconductor company’s stock valued at $647,067,000 after purchasing an additional 418,077 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Wall Street Analyst Weigh In

LRCX has been the topic of several research analyst reports. HSBC set a $127.00 price objective on shares of Lam Research and gave the stock a “hold” rating in a research note on Tuesday, September 30th. Morgan Stanley increased their price target on Lam Research from $125.00 to $137.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 23rd. Cowen reaffirmed a “buy” rating on shares of Lam Research in a report on Thursday, October 23rd. Wells Fargo & Company boosted their price objective on Lam Research from $135.00 to $145.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 23rd. Finally, Summit Insights cut Lam Research from a “buy” rating to a “hold” rating in a report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $148.54.

Insiders Place Their Bets

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Ava Harter sold 9,010 shares of the stock in a transaction on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the transaction, the insider directly owned 56,786 shares in the company, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their position. The SEC filing for this sale provides additional information. 0.31% of the stock is currently owned by insiders.

Lam Research Price Performance

Lam Research stock opened at $161.01 on Friday. The business’s 50-day simple moving average is $127.98 and its 200 day simple moving average is $102.36. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock has a market cap of $202.23 billion, a price-to-earnings ratio of 35.46, a P/E/G ratio of 1.68 and a beta of 1.84. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $165.22.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s revenue was up 27.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th were paid a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, September 24th. This is a boost from Lam Research’s previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. Lam Research’s payout ratio is 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.